Project/Area Number |
23592689
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Emergency medicine
|
Research Institution | Aichi Medical University |
Principal Investigator |
FENG Guo-Gang 愛知医科大学, 医学部, 講師 (70351111)
|
Co-Investigator(Kenkyū-buntansha) |
HONDA Takashi 名古屋大学, 医学(系)研究科(研究院), 特任助教 (10378052)
|
Project Period (FY) |
2011 – 2013
|
Project Status |
Completed (Fiscal Year 2013)
|
Budget Amount *help |
¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2013: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2012: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2011: ¥3,380,000 (Direct Cost: ¥2,600,000、Indirect Cost: ¥780,000)
|
Keywords | エンドトキシン(LPS) / クッパー細胞ptosis / TNFα / caspase-3 / アポトーシス / Bcl-2 / Bcl-xL / cytochrome c / LPS / クッパー細胞、 / bupivacaine / NF-κB / エンドトキシン / クッパー細胞 / プロポフォール / WD-repeat protein / チトクロムc |
Research Abstract |
Endothxin (LPS) causes hepatocytic apoptosis and liver dysfunction, as described in cases of sepsis. In this study, we therefore investigated the functions of a new WD-repeat domain containing protein naofen (WDR35) in LPS-induced liver dysfunction. LPS activated Kuppfer cells and released cytokines, such as TNF-alpha. Which then increased mRNA and protein expression of naofen in hepatocytes. Naofen/WDR35 inhibited expressions of anti-apoptotic proteins Bcl-2 and Bcl-xL, and stimulated apoptosis of hepatocytes. These results suggested that naofen may be involved in endotoxin-induced liver injury, and as a new therapeutic targets for endotoxin-induced liver injury therapy.
|